Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)

Condition:   Active Psoriatic Arthritis Interventions:   Other: BMS-986165 Placebo;   Drug: BMS-986165 Dose A;   Drug: BMS-986165 Dose B;   Drug: Ustekinumab;   Other: Ustekinumab Placebo Sponsor:   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials